No Data
No Data
Biora Therapeutics Achieves ISO 13485 Certification, Demonstrating The Co's Commitment To Compliance With The Most Rigorous Global Regulatory And Quality Standards
Express News | Biora Therapeutics Inc - No Payments Will Be Made by Either Party
Express News | Biora Therapeutics - in Sept 2024, Following Hearing on Biora's Summary Judgment Motion, Co and Ravgen Inc Entered Into Settlement Agreement
Biora Therapeutics Granted Extension to Regain Compliance With Nasdaq
Biora Therapeutics Announces Positive Nasdaq Listing Decision
Biora Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference